• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Voice Preservation

Making Our Voices Heard

Speech is a key part of a person’s identity. Voice matters to personal identity and expression, and connection with family and friends. The majority of people living with ALS/MND are eventually robbed of this fundamental part of their humanity.

This can be overcome using voice preservation technologies, but our research shows this is not equitably accessible. The Alliance seeks to provide universal access to technology to improve the quality of life of people living with ALS/MND. The ideal for every individual living with ALS/MND worldwide is to have the right to access voice preservation upon diagnosis.

The Voice Preservation Project

The Alliance, through a collaboration between Hospital Universitario Nacional de Colombia (HUN) and the Asociación Colombiana de ELA (ACELA), has launched a pilot project to deliver voice preservation technology to people living with ALS/MND in Colombia. This will serve as the basis on which future plans will be made on how best to scale to reach more people around the world.

If you would like to join us in expanding our reach to more people, please donate. We deeply appreciate your support.

Watch this video to find out more from the Alliance and its Information Technology Advisory Council (ITAC).

https://www.als-mnd.org/wp-content/uploads/2023/06/Voice-Preservation-ITAC-Intro.mp4

Watch this video to hear from Orlando Ruiz, founder of ACELA and a person living with ALS/MND, as he emphasizes the devastation of losing your voice. He goes on to explain the potential of voice banking technology to preserve dignity, autonomy and identity, and ensure no one loses their voice to ALS/MND.

 

Keep Up To Date

This project is in development and more details and information are coming soon! If you are interested in learning more, sign up to get periodic updates as the work progresses.

Subscribe

* indicates required
 
 

 

Disclaimer: Voice preservation is not designed, intended or made available for diagnosis, treatment or prevention of diseases or for use as a medical device. It is also not designed or intended to replace or be a substitute for professional medical advice, diagnosis, treatment or judgment.

Primary Sidebar

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Art Eggert, USA

    Art Eggert, USA

  • Olga Cosentino, Argentina

    Olga Cosentino, Argentina

  • Amparo Muriel Engativa, Colombia

    Amparo Muriel Engativa, Colombia

  • Dorette Lüdi, Switzerland

    Dorette Lüdi, Switzerland

  • Michael Lee, Australia

    Michael Lee, Australia

  • Mike Rannie, Canada

    Mike Rannie, Canada

  • Mauril Bélanger, Canada

    Mauril Bélanger, Canada

  • Fernando Ocampo Cardona, Colombia

    Fernando Ocampo Cardona, Colombia

  • Steven Spencer, New Zealand

    Steven Spencer, New Zealand

  • Denis Blais, Canada

    Denis Blais, Canada

  • Jorge Luis Fernández Romero, Mexico

    Jorge Luis Fernández Romero, Mexico

  • Angela Jansen, Germany

    Angela Jansen, Germany

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Daniela Maria Daverio, Argentina

    Daniela Maria Daverio, Argentina

  • Jack Buzby, USA

    Jack Buzby, USA

  • Conny van der Meijden, Netherlands

    Conny van der Meijden, Netherlands

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Danny Reviers, Belgium

    Danny Reviers, Belgium
    DannyReviers

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • Sally Pauls, USA

    Sally Pauls, USA

  • Mike Cels, Canada

    Mike Cels, Canada

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Steve Gallagher, Canada

    Steve Gallagher, Canada
    Picture1

  • Irene McCaughey, Australia

    Irene McCaughey, Australia

  • Philip Brindle, England

    Philip Brindle, England

  • Ana María Zavala, Mexico

    Ana María Zavala, Mexico

  • Dick Dayton, USA

    Dick Dayton, USA

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Elisabeth Zahnd, Switzerland

    Elisabeth Zahnd, Switzerland

  • Norm MacIsaac, Canada

    Norm MacIsaac, Canada

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Semra Gokalp, Turkey

    Semra Gokalp, Turkey

  • Mark Miller, UK

    Mark Miller, UK

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Brian Parsons, Canada

    Brian Parsons, Canada

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Jon Newsome, USA

    Jon Newsome, USA

  • Ali Var, Turkey

    Ali Var, Turkey

  • Monica Soriano, Argentina

    Monica Soriano, Argentina

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Rosie Riley, USA

    Rosie Riley, USA

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login